SLC2A1 and cancer: The overall analysis showed that high GLUT-1 expression was associated with poor OS in cancer (HR = 1.833, 95% CI: 1.597–2.069; P < 0.0001) with no significant heterogeneity (I2 = 0%) (Table 1 and Figure 2).